Du Ruobing, Ba Kai, Yang Yaxin, Zhao Yueyue, Lin Yupeng
Department of Oral and Maxillofacial Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Department of Nursing Teaching and Research, the Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Arch Med Sci. 2024 Jan 4;20(1):189-195. doi: 10.5114/aoms/171907. eCollection 2024.
Timely and effective treatments of pericoronitis are very important. We aimed to evaluate the role of ornidazole in the treatment of pericoronitis, to provide insights for clinical pericoronitis treatment.
The PubMed, Clinical trials, EMBASE, Science Direct, Cochrane Library, China National Knowledge Infrastructure (CNKI), Weipu and Wanfang databases were searched to find randomized controlled trials (RCTs) of ornidazole in the treatment of pericoronitis from the establishment of the database to March 15, 2023. Review Manager 5.3 software was used for meta-analysis.
A total of 16 RCTs involving 2004 patients were included. The results of the meta-analysis showed that the effective rate of ornidazole treatment was significantly higher than that of the routine treatment group (RR = 1.22, 95% CI (1.15, 1.29), < 0.001). Ornidazole treatment was beneficial to reduce the oral bacterial density (MD = -26.13, 95% CI (-32.08, -21.51)), time to pain disappearance (MD = -0.64, 95% CI (-0.92, -0.17)) and time to disappearance of redness and swelling of the teeth crown (MD = -1.45, 95% CI (-2.43, -1.01)) compared to the routine treatment (all = 0.05). No publication bias was found by the funnel plots and Egger test ( = 0.206).
Ornidazole is effective in the treatment of pericoronitis, with more advantages. Still, the effects and safety of ornidazole in the treatment of pericoronitis need to be evaluated by more high-quality RCTs with larger sample sizes.
及时有效地治疗冠周炎非常重要。我们旨在评估奥硝唑在冠周炎治疗中的作用,为临床冠周炎治疗提供参考。
检索了PubMed、Clinical trials、EMBASE、Science Direct、Cochrane Library、中国知网(CNKI)、维普和万方数据库,以查找从数据库建立至2023年3月15日期间奥硝唑治疗冠周炎的随机对照试验(RCT)。使用Review Manager 5.3软件进行荟萃分析。
共纳入16项RCT,涉及2004例患者。荟萃分析结果显示,奥硝唑治疗的有效率显著高于常规治疗组(RR = 1.22,95%CI(1.15,1.29),P < 0.001)。与常规治疗相比,奥硝唑治疗有利于降低口腔细菌密度(MD = -26.13,95%CI(-32.08,-21.51))、疼痛消失时间(MD = -0.64,95%CI(-0.92,-0.17))和牙冠红肿消失时间(MD = -1.45,95%CI(-2.43,-1.01))(均P < 0.05)。漏斗图和Egger检验未发现发表偏倚(P = 0.206)。
奥硝唑治疗冠周炎有效,具有更多优势。然而,奥硝唑治疗冠周炎的疗效和安全性仍需更多大样本高质量的RCT进行评估。